News24

ZMapp Ebola drug stock finished

2014-08-12 21:26

Washington - The supply of the experimental drug ZMapp used to treat people with the Ebola virus has been exhausted, the US company that makes the medication said on Monday.

"We have complied with every request for ZMapp that had the necessary legal/regulatory authorisation," Mapp Biopharmaceuticals said in a statement.

The company declined to say where the drug has been sent, but said in all cases it was provided at no cost.

SAPA
Read more on:    mapp biopharmaceuticals us ebola zmapp

More Stories in Africa

«Back
Ad:Metropolitan Family Funeral Plan from R36 p.m.